Old Web
English
Sign In
Acemap
>
Paper
>
Serum IL-6 (sIL-6) predicts overall survival in patients with metastatic breast cancer (MBC)
Serum IL-6 (sIL-6) predicts overall survival in patients with metastatic breast cancer (MBC)
2001
S Junius
Ina Benoy
R. Salgado
R Weytjens
P. van Dam
P. Huget
J. Lemmens
L. Dirix
Keywords:
Breast cancer
Immunology
Interleukin 6
Metastatic breast cancer
Medicine
Pathology
Internal medicine
in patient
Oncology
overall survival
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]